[go: up one dir, main page]

UY24937A1 - Forma hidratada de un derivado de 4-nitrobenzamida - Google Patents

Forma hidratada de un derivado de 4-nitrobenzamida

Info

Publication number
UY24937A1
UY24937A1 UY24937A UY24937A UY24937A1 UY 24937 A1 UY24937 A1 UY 24937A1 UY 24937 A UY24937 A UY 24937A UY 24937 A UY24937 A UY 24937A UY 24937 A1 UY24937 A1 UY 24937A1
Authority
UY
Uruguay
Prior art keywords
gives
product
nitrobenzamide
pharmaceutically acceptable
spectrum containing
Prior art date
Application number
UY24937A
Other languages
English (en)
Inventor
Paul Jeffrey Westlake
Graham Ralph Slater
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of UY24937A1 publication Critical patent/UY24937A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Esta invención se refiere a un nuevo producto farmacéutico, a un procedimiento para la preparación del producto farmacéutico y al uso del producto en medicina. El producto de la invención es el Hidrocloruro de N-(3-((2-(3,4-dimetoxifenil)etil)amino)propil)-4-nitrobenzamida hidratado, caracterizado porque: (i) contiene agua en la proporción de 1,7 a 2,4 equivalentes molares; y/o (ii) tiene un punto de fusión superior a 145s C; y/o (iii) da un espectro infrarrojo que contiene picos a 3510, 3342, 3076, 1665, 1598, 1343, 1330, 1216 y 801cm-1; y/o (iv) da un espectro de resonancia magnética nuclear en estado sólido que contiene desplazamientos químicos; y/o (v) da un patrón de difracción en polvo de rayos x (XPRD). Este compuesto o sus sales farmacéuticamente aceptables y/o uno de sus solvatos farmacéuticamente aceptables se utilizan en el tratamiento o profilaxis de arritmias y los trastornos isquémicos del ritmo.
UY24937A 1997-03-27 1998-03-26 Forma hidratada de un derivado de 4-nitrobenzamida UY24937A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9706376.2A GB9706376D0 (en) 1997-03-27 1997-03-27 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
UY24937A1 true UY24937A1 (es) 2000-12-29

Family

ID=10809958

Family Applications (1)

Application Number Title Priority Date Filing Date
UY24937A UY24937A1 (es) 1997-03-27 1998-03-26 Forma hidratada de un derivado de 4-nitrobenzamida

Country Status (37)

Country Link
US (1) US20040092771A1 (es)
EP (1) EP0971882B1 (es)
JP (1) JP2001518088A (es)
KR (1) KR20010005566A (es)
CN (1) CN1257478A (es)
AP (1) AP1205A (es)
AT (1) ATE228997T1 (es)
AU (1) AU741476B2 (es)
BG (1) BG103829A (es)
BR (1) BR9809054A (es)
CA (1) CA2285197A1 (es)
DE (1) DE69809891T2 (es)
DK (1) DK0971882T3 (es)
DZ (1) DZ2452A1 (es)
EA (1) EA002439B1 (es)
EG (1) EG21226A (es)
ES (1) ES2189163T3 (es)
GB (1) GB9706376D0 (es)
HK (1) HK1025089A1 (es)
HU (1) HUP0001683A3 (es)
ID (1) ID22787A (es)
IL (1) IL132042A0 (es)
IN (1) IN188180B (es)
MA (1) MA26477A1 (es)
NO (1) NO994682L (es)
NZ (1) NZ337794A (es)
OA (1) OA11200A (es)
PE (1) PE61799A1 (es)
PL (1) PL335879A1 (es)
PT (1) PT971882E (es)
SK (1) SK283056B6 (es)
TR (1) TR199902356T2 (es)
TW (1) TW518318B (es)
UA (1) UA57066C2 (es)
UY (1) UY24937A1 (es)
WO (1) WO1998043947A1 (es)
ZA (1) ZA982558B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923934D0 (en) * 1999-10-08 1999-12-08 Smithkline Beecham Plc Novel pharmaceutical
GB9923933D0 (en) * 1999-10-08 1999-12-08 Smithkline Beecham Lab Novel pharmaceutical
US8483008B2 (en) * 2008-11-08 2013-07-09 Westerngeco L.L.C. Coil shooting mode

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726267B1 (fr) * 1994-10-26 1998-01-02 Smithkline Beecham Lab Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer

Also Published As

Publication number Publication date
NO994682D0 (no) 1999-09-24
SK283056B6 (sk) 2003-02-04
TW518318B (en) 2003-01-21
NO994682L (no) 1999-09-24
IN188180B (es) 2002-08-31
UA57066C2 (uk) 2003-06-16
CN1257478A (zh) 2000-06-21
BR9809054A (pt) 2000-08-01
BG103829A (bg) 2000-04-28
EA199900879A1 (ru) 2000-04-24
DZ2452A1 (fr) 2003-01-18
PT971882E (pt) 2003-04-30
HUP0001683A2 (hu) 2000-09-28
JP2001518088A (ja) 2001-10-09
HUP0001683A3 (en) 2002-11-28
ES2189163T3 (es) 2003-07-01
AU741476B2 (en) 2001-11-29
EP0971882B1 (en) 2002-12-04
ZA982558B (en) 1999-09-27
PE61799A1 (es) 1999-09-10
EA002439B1 (ru) 2002-04-25
NZ337794A (en) 2001-06-29
IL132042A0 (en) 2001-03-19
AP9901651A0 (en) 1999-09-30
OA11200A (en) 2003-05-21
US20040092771A1 (en) 2004-05-13
AP1205A (en) 2003-09-17
DE69809891D1 (de) 2003-01-16
HK1025089A1 (en) 2000-11-03
EP0971882A1 (en) 2000-01-19
PL335879A1 (en) 2000-05-22
DK0971882T3 (da) 2003-03-31
TR199902356T2 (xx) 2000-01-21
DE69809891T2 (de) 2003-07-24
MA26477A1 (fr) 2004-12-20
GB9706376D0 (en) 1997-05-14
ID22787A (id) 1999-12-09
KR20010005566A (ko) 2001-01-15
EG21226A (en) 2001-03-31
CA2285197A1 (en) 1998-10-08
AU7334198A (en) 1998-10-22
WO1998043947A1 (en) 1998-10-08
ATE228997T1 (de) 2002-12-15
SK130299A3 (en) 2000-05-16

Similar Documents

Publication Publication Date Title
DE60115394D1 (de) Benzamide und ähnliche inhibitoren vom faktor xa
AR008853A1 (es) Nuevos compuestos farmaceuticamente activos, su uso en la fabricacion de medicamentos, metodo de tratamiento, composicion farmaceutica, compuestosintermediarios y proceso para la fabricacion de dichos compuestos
GEP20053600B (en) 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
NO308248B1 (no) Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat
BG106586A (en) Pyrazolopyramidines as therapeutic agents
LU90410I2 (fr) Milnacipran (chlorhydrate)
SV2003000633A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
DE69527506D1 (de) Delta 12,16-isotaxol analoge mit antineoplastischer wirkung und pharmazeutische zusammensetzungen sie enthaltend
GB9211172D0 (en) Compounds
JO2321B1 (en) 4-phenyl-pyridine derivatives
GB9305295D0 (en) Therapeutic compounds
GB9310095D0 (en) Therapeutic compounds
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
AR023560A1 (es) Una forma polimorfica de acido maleico de un derivado de tiazolidin-2,4-diona, composicion farmaceutica y el uso de los mismos para la preparacion de unmedicamento
UY24937A1 (es) Forma hidratada de un derivado de 4-nitrobenzamida
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
NO964750L (no) Amid-derivater og deres terapeutiske anvendelse
IL127177A (en) ANTIPYSYCHOTIC 5-(1, 3, 4, 4a, 5, 9b-HEXAHYDRO-PYRIDO (3, 4-b) INDOL-2-YLALKYL) PYRIMIDIN-4-ONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO940274D0 (no) 2-(4-(-azolbutyl)-1-piperazinyl)-5-hydroksy-pyrimidinderivater, deres fremstilling og anvendelse som legemidler
MX9400165A (es) Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.
NO933241L (no) Aminosyrer nyttige ved terapi av osteoartikulaere paavirkninger
NO973340L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20071105